Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T

被引:160
作者
Tkác, I
Henry, PG
Andersen, P
Keene, CD
Low, WC
Gruetter, R
机构
[1] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA
关键词
in vivo NMR spectroscopy; shimming; mouse brain; quantification; neurochemical profile;
D O I
10.1002/mrm.20184
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
An efficient shim system and an optimized localization sequence were used to measure in vivo H-1 NMR spectra from cerebral cortex, hippocampus, striatum, and cerebellum of C57BL/6 mice at 9.4 T. The combination of automatic first- and second-order shimming (FASTMAP) with strong custom-designed second-order shim coils (shim strength up to 0.04 mT/cm(2)) was crucial to achieve high spectral resolution (water line width of 11-14 Hz). Requirements for second-order shim strengths to compensate field inhomogeneities in the mouse brain at 9.4 T were assessed. The achieved spectral quality (resolution, S/N, water suppression, localization performance) allowed reliable quantification of 16 brain metabolites (LCModel analysis) from 5-10-muL brain volumes. Significant regional differences (up to 2-fold, P < 0.05) were found for all quantified metabolites but Asp, Glc, and Gln. In contrast, H-1 NMR spectra measured from the striatum of C57BL/6, CBA, and CBA/BL6 mice revealed only small (<13%, P < 0.05) interstrain differences in Gln, Glu, Ins, Lac, NAAG, and PE. It is concluded that H-1 NMR spectroscopy at 9.4 T can provide precise biochemical information from distinct regions of the mouse brain noninvasively that can be used for monitoring of disease progression and treatment as well as phenotyping in transgenic mice models. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:478 / 484
页数:7
相关论文
共 46 条
[1]   A half-volume coil for efficient proton decoupling in humans at 4 Tesla [J].
Adriany, G ;
Gruetter, R .
JOURNAL OF MAGNETIC RESONANCE, 1997, 125 (01) :178-184
[2]  
Aguzzi A, 2000, ANN NY ACAD SCI, V920, P140
[3]   Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease [J].
Andreassen, OA ;
Dedeoglu, A ;
Ferrante, RJ ;
Jenkins, BG ;
Ferrante, KL ;
Thomas, M ;
Friedlich, A ;
Browne, SE ;
Schilling, G ;
Borchelt, DR ;
Hersch, SM ;
Ross, CA ;
Beal, MF .
NEUROBIOLOGY OF DISEASE, 2001, 8 (03) :479-491
[4]   Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation [J].
Andreassen, OA ;
Jenkins, BG ;
Dedeoglu, A ;
Ferrante, KL ;
Bogdanov, MB ;
Kaddurah-Daouk, R ;
Beal, MF .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (02) :383-390
[5]   Transgenic models of Huntington's disease [J].
Bates, GP ;
Mangiarini, L ;
Mahal, A ;
Davies, SW .
HUMAN MOLECULAR GENETICS, 1997, 6 (10) :1633-1637
[6]  
Beckmann N, 2000, MAGNET RESON MED, V44, P252, DOI 10.1002/1522-2594(200008)44:2<252::AID-MRM12>3.0.CO
[7]  
2-G
[8]   SPATIAL LOCALIZATION IN NMR-SPECTROSCOPY INVIVO [J].
BOTTOMLEY, PA .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 508 :333-348
[9]   Cramer-Rao bounds: an evaluation tool for quantitation [J].
Cavassila, S ;
Deval, S ;
Huegen, C ;
van Ormondt, D ;
Graveron-Demilly, D .
NMR IN BIOMEDICINE, 2001, 14 (04) :278-283
[10]   In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models [J].
Choi, IY ;
Lee, SP ;
Guilfoyle, DN ;
Helpern, JA .
NEUROCHEMICAL RESEARCH, 2003, 28 (07) :987-1001